Leadership

The members of the Board of Directors of the International PNH Interest Group are recognized experts in the care and management of PNH. Together, they bring to IPIG a vast depth and breadth of knowledge about PNH and related conditions.

Board members are elected for a three-year term by the membership at the Annual Meeting of Members, and are eligible to serve two successive terms. To ensure adequate member representation, at least one director is elected from each of three geographic areas: Europe, Japan/Asia-Pacific, and North America.

The current members of the Board are:

  • Peter Hillmen MB, ChB, PhD, Chairman

    Leeds Teaching Hospitals NHS Trust
    Leeds
    United Kingdom

  • Taroh Kinoshita PhD, Secretary

    Research Institute for Microbial Diseases
    Osaka University
    Osaka
    Japan

  • Régis Peffault de Latour MD, PhD, Hematology-Bone Marrow Transplantation

    Research Institute for Microbial Diseases
    Hôpital Saint-Louis
    Paris
    France

  • Petra Muus MD, PhD

    University Medical Centre
    Radboud University
    Nijmegen
    Netherlands

  • Shinji Nakao MD, PhD

    Cellular Transplantation Biology
    Kanazawa University Graduate School of Medical Science
    Kanazawa
    Ishikawa
    Japan

  • Charles J. Parker MD, Professor of Medicine, Treasurer

    Division of Hematology and Bone Marrow Transplantation
    University of Utah School of Medicine
    Salt Lake City
    Utah
    USA

  • Antonio M. Risitano MD, PhD, Division of Hematology

    Federico II University
    Naples
    Italy

  • Russell E. Ware MD, PhD

    Texas Children’s Center for Global Health
    Houston
    Texas
    USA

  • Neal S. Young MD

    Washington DC
    USA